A 0 1 0 1 O
minimum 2 9 2 9 O
washout 10 17 10 17 O
period 18 24 18 24 O
of 25 27 25 27 O
4 28 29 28 29 B-lower_bound
weeks 30 35 30 35 I-lower_bound
after 36 41 36 41 O
previous 42 50 42 50 O
CTCL 51 55 51 55 B-treatment
therapy 56 63 56 63 I-treatment
is 64 66 64 66 O
recommended 67 78 67 78 O
before 79 85 79 85 O
the 86 89 86 89 O
first 90 95 90 95 O
dose 96 100 96 100 O
of 101 103 101 103 O
E7777 104 109 104 109 B-treatment

A 0 1 110 111 O
shorter 2 9 112 119 O
washout 10 17 120 127 O
may 18 21 128 131 O
be 22 24 132 134 O
allowed 25 32 135 142 O
if 33 35 143 145 O
participant 36 47 146 157 O
is 48 50 158 160 O
experiencing 51 63 161 173 O
progressive 64 75 174 185 O
disease 76 83 186 193 O
despite 84 91 194 201 O
ongoing 92 99 202 209 B-treatment
treatment 100 109 210 219 I-treatment

Active 0 6 220 226 O
malignancy 7 17 227 237 B-cancer
( 18 19 238 239 O
except 19 25 239 245 O
for 26 29 246 249 O
CTCL 30 34 250 254 B-cancer
, 34 35 254 255 O
definitively 36 48 256 268 O
treated 49 56 269 276 O
basal 57 62 277 282 B-cancer
or 63 65 283 285 I-cancer
squamous 66 74 286 294 I-cancer
cell 75 79 295 299 I-cancer
carcinoma 80 89 300 309 I-cancer
of 90 92 310 312 I-cancer
the 93 96 313 316 I-cancer
skin 97 101 317 321 I-cancer
, 101 102 321 322 O
and 103 106 323 326 O
carcinoma 107 116 327 336 B-cancer
in 117 119 337 339 I-cancer
- 119 120 339 340 I-cancer
situ 120 124 340 344 I-cancer
of 125 127 345 347 I-cancer
the 128 131 348 351 I-cancer
cervix 132 138 352 358 I-cancer
) 138 139 358 359 O
within 140 146 360 366 O
the 147 150 367 370 O
past 151 155 371 375 B-upper_bound
24 156 158 376 378 I-upper_bound
months 159 165 379 385 I-upper_bound

Adequate 0 8 386 394 O
renal 9 14 395 400 O
function 15 23 401 409 O
as 24 26 410 412 O
evidenced 27 36 413 422 O
by 37 39 423 425 O
serum 40 45 426 431 B-clinical_variable
creatinine 46 56 432 442 I-clinical_variable
less 57 61 443 447 O
than 62 66 448 452 O
or 67 69 453 455 O
equal 70 75 456 461 O
to 76 78 462 464 O
1.8 79 82 465 468 B-upper_bound
mg 83 85 469 471 I-upper_bound
/ 85 86 471 472 I-upper_bound
dL 86 88 472 474 I-upper_bound
( 89 90 475 476 I-upper_bound
158 90 93 476 479 I-upper_bound
umol 94 98 480 484 I-upper_bound
/ 98 99 484 485 I-upper_bound
L 99 100 485 486 I-upper_bound
) 100 101 486 487 I-upper_bound

Age 0 3 488 491 B-age
greater 4 11 492 499 O
than 12 16 500 504 O
or 17 19 505 507 O
equal 20 25 508 513 O
to 26 28 514 516 O
18 29 31 517 519 B-lower_bound
years 32 37 520 525 I-lower_bound

All 0 3 526 529 O
females 4 11 530 537 B-gender
will 12 16 538 542 O
be 17 19 543 545 O
considered 20 30 546 556 O
to 31 33 557 559 O
be 34 36 560 562 O
of 37 39 563 565 O
childbearing 40 52 566 578 O
potential 53 62 579 588 O
unless 63 69 589 595 O
they 70 74 596 600 O
are 75 78 601 604 O
postmenopausal 79 93 605 619 O
or 94 96 620 622 O
have 97 101 623 627 O
been 102 106 628 632 O
sterilized 107 117 633 643 O
surgically 118 128 644 654 O

CD25 0 4 655 659 B-clinical_variable
assay 5 10 660 665 B-treatment
- 10 11 665 666 O
positive 11 19 666 674 O
tumor 20 25 675 680 B-cancer
, 25 26 680 681 O
defined 27 34 682 689 O
as 35 37 690 692 O
detectable 38 48 693 703 O
CD25 49 53 704 708 O
on 54 56 709 711 O
greater 57 64 712 719 O
than 65 69 720 724 O
or 70 72 725 727 O
equal 73 78 728 733 O
to 79 81 734 736 O
20 82 84 737 739 B-lower_bound
% 84 85 739 740 I-lower_bound
of 86 88 741 743 O
total 89 94 744 749 O
lymphoid 95 103 750 758 B-cancer
infiltrate 104 114 759 769 I-cancer
in 115 117 770 772 O
biopsied 118 126 773 781 B-treatment
lesions 127 134 782 789 I-treatment
by 135 137 790 792 O
immunohistochemistry 138 158 793 813 B-treatment

CTCL 0 4 814 818 B-cancer
disease 5 12 819 826 O
stage 13 18 827 832 O
at 19 21 833 835 O
study 22 27 836 841 O
entry 28 33 842 847 O
as 34 36 848 850 O
follows 37 44 851 858 O
, 44 45 858 859 O
according 46 55 860 869 O
to 56 58 870 872 O
ISCL 59 63 873 877 O
/ 63 64 877 878 O
EORTC 64 69 878 883 O
( 70 71 884 885 O
Olsen 71 76 885 890 O
2011 77 81 891 895 O
) 81 82 895 896 O

Eastern 0 7 897 904 B-clinical_variable
Cooperative 8 19 905 916 I-clinical_variable
Oncology 20 28 917 925 I-clinical_variable
Group 29 34 926 931 I-clinical_variable
( 35 36 932 933 I-clinical_variable
ECOG 36 40 933 937 I-clinical_variable
) 40 41 937 938 I-clinical_variable
performance 42 53 939 950 I-clinical_variable
status 54 60 951 957 I-clinical_variable
0 61 62 958 959 B-lower_bound
, 62 63 959 960 O
1 64 65 961 962 B-upper_bound
, 65 66 962 963 O
or 67 69 964 966 O
2 70 71 967 968 B-upper_bound
in 72 74 969 971 O
the 75 78 972 975 O
Lead 79 83 976 980 O
- 83 84 980 981 O
In 84 86 981 983 O
Part 87 91 984 988 O
and 92 95 989 992 O
performance 96 107 993 1004 O
status 108 114 1005 1011 O
of 115 117 1012 1014 O
0 118 119 1015 1016 O
or 120 122 1017 1019 O
1 123 124 1020 1021 O
in 125 127 1022 1024 O
the 128 131 1025 1028 O
Main 132 136 1029 1033 O
Study 137 142 1034 1039 O

Females 0 7 1040 1047 B-gender
may 8 11 1048 1051 O
not 12 15 1052 1055 O
be 16 18 1056 1058 O
lactating 19 28 1059 1068 O
or 29 31 1069 1071 O
pregnant 32 40 1072 1080 B-pregnancy
at 41 43 1081 1083 O
Screening 44 53 1084 1093 O
or 54 56 1094 1096 O
Baseline 57 65 1097 1105 O

Females 0 7 1106 1113 B-gender
who 8 11 1114 1117 O
are 12 15 1118 1121 O
pregnant 16 24 1122 1130 B-pregnancy
( 25 26 1131 1132 O
positive 26 34 1132 1140 O
urine 35 40 1141 1146 O
test 41 45 1147 1151 O
) 45 46 1151 1152 O
or 47 49 1153 1155 O
breastfeeding 50 63 1156 1169 O

Histopathologic 0 15 1170 1185 O
diagnosis 16 25 1186 1195 O
of 26 28 1196 1198 O
CTCL 29 33 1199 1203 B-cancer
( 34 35 1204 1205 O
mycosis 35 42 1205 1212 B-chronic_disease
fungoides 43 52 1213 1222 I-chronic_disease
[ 53 54 1223 1224 I-chronic_disease
MF 54 56 1224 1226 I-chronic_disease
] 56 57 1226 1227 I-chronic_disease
or 58 60 1228 1230 O
Sezary 61 67 1231 1237 B-chronic_disease
Syndrome 68 76 1238 1246 I-chronic_disease
[ 77 78 1247 1248 I-chronic_disease
SS 78 80 1248 1250 I-chronic_disease
] 80 81 1250 1251 I-chronic_disease
) 81 82 1251 1252 O
, 82 83 1252 1253 O
confirmed 84 93 1254 1263 O
by 94 96 1264 1266 O
skin 97 101 1267 1271 B-treatment
biopsy 102 108 1272 1278 I-treatment
, 108 109 1278 1279 O
or 110 112 1280 1282 O
lymph 113 118 1283 1288 O
node 119 123 1289 1293 O
, 123 124 1293 1294 O
or 125 127 1295 1297 O
blood 128 133 1298 1303 O
assessment 134 144 1304 1314 O
, 144 145 1314 1315 O
of 146 148 1316 1318 O
current 149 156 1319 1326 O
disease 157 164 1327 1334 O

History 0 7 1335 1342 O
of 8 10 1343 1345 O
prior 11 16 1346 1351 B-treatment
therapies 17 26 1352 1361 I-treatment
for 27 30 1362 1365 O
CTCL 31 35 1366 1370 B-cancer
as 36 38 1371 1373 O
follows 39 46 1374 1381 O
: 46 47 1381 1382 O
must 48 52 1383 1387 O
have 53 57 1388 1392 O
had 58 61 1393 1396 O
prior 62 67 1397 1402 B-treatment
therapy 68 75 1403 1410 I-treatment
, 75 76 1410 1411 O
any 77 80 1412 1415 O
number 81 87 1416 1422 O
of 88 90 1423 1425 O
prior 91 96 1426 1431 O
therapies 97 106 1432 1441 O
allowed 107 114 1442 1449 O

History 0 7 1450 1457 O
of 8 10 1458 1460 O
uncontrolled 11 23 1461 1473 O
seizure 24 31 1474 1481 B-chronic_disease
disorder 32 40 1482 1490 I-chronic_disease
or 41 43 1491 1493 O
active 44 50 1494 1500 O
central 51 58 1501 1508 B-chronic_disease
nervous 59 66 1509 1516 I-chronic_disease
system 67 73 1517 1523 I-chronic_disease
disease 74 81 1524 1531 I-chronic_disease

Known 0 5 1532 1537 O
human 6 11 1538 1543 B-chronic_disease
immunodeficiency 12 28 1544 1560 I-chronic_disease
virus 29 34 1561 1566 I-chronic_disease
( 35 36 1567 1568 I-chronic_disease
HIV 36 39 1568 1571 I-chronic_disease
) 39 40 1571 1572 I-chronic_disease
infection 41 50 1573 1582 I-chronic_disease
; 50 51 1582 1583 O
known 52 57 1584 1589 O
active 58 64 1590 1596 O
hepatitis 65 74 1597 1606 B-chronic_disease
B 75 76 1607 1608 I-chronic_disease
or 77 79 1609 1611 O
hepatitis 80 89 1612 1621 B-chronic_disease
C 90 91 1622 1623 I-chronic_disease
infection 92 101 1624 1633 I-chronic_disease

Lead 0 4 1634 1638 O
- 4 5 1638 1639 O
In 5 7 1639 1641 O
Part 8 12 1642 1646 O
: 12 13 1646 1647 O
Stage 14 19 1648 1653 B-cancer
IA 20 22 1654 1656 I-cancer
- 23 24 1657 1658 I-cancer
IV 25 27 1659 1661 I-cancer
, 27 28 1661 1662 O
except 29 35 1663 1669 O
participants 36 48 1670 1682 O
with 49 53 1683 1687 O
CNS 54 57 1688 1691 O
involvement 58 69 1692 1703 O

Life 0 4 1704 1708 B-clinical_variable
expectancy 5 15 1709 1719 I-clinical_variable
greater 16 23 1720 1727 O
than 24 28 1728 1732 O
or 29 31 1733 1735 O
equal 32 37 1736 1741 O
to 38 40 1742 1744 O
3 41 42 1745 1746 B-lower_bound
months 43 49 1747 1753 I-lower_bound
in 50 52 1754 1756 O
the 53 56 1757 1760 O
Lead 57 61 1761 1765 O
- 61 62 1765 1766 O
In 62 64 1766 1768 O
Part 65 69 1769 1773 O
and 70 73 1774 1777 O
greater 74 81 1778 1785 O
than 82 86 1786 1790 O
or 87 89 1791 1793 O
equal 90 95 1794 1799 O
to 96 98 1800 1802 O
12 99 101 1803 1805 B-lower_bound
months 102 108 1806 1812 I-lower_bound
in 109 111 1813 1815 O
the 112 115 1816 1819 O
Main 116 120 1820 1824 O
Study 121 126 1825 1830 O

Main 0 4 1831 1835 O
Study 5 10 1836 1841 O
: 10 11 1841 1842 O
Stage 12 17 1843 1848 B-lower_bound
IA 18 20 1849 1851 I-lower_bound
- 21 22 1852 1853 O
IVA2 23 27 1854 1858 B-upper_bound
including 28 37 1859 1868 O
lymph 38 43 1869 1874 O
node 44 48 1875 1879 O
disease 49 56 1880 1887 O
N2 57 59 1888 1890 O
and 60 63 1891 1894 O
N3 64 66 1895 1897 O

Major 0 5 1898 1903 B-treatment
surgery 6 13 1904 1911 I-treatment
within 14 20 1912 1918 O
2 21 22 1919 1920 B-upper_bound
weeks 23 28 1921 1926 I-upper_bound
of 29 31 1927 1929 O
study 32 37 1930 1935 O
enrollment 38 48 1936 1946 O

Male 0 4 1947 1951 B-gender
participants 5 17 1952 1964 I-gender
must 18 22 1965 1969 O
have 23 27 1970 1974 O
had 28 31 1975 1978 O
a 32 33 1979 1980 O
successful 34 44 1981 1991 O
vasectomy 45 54 1992 2001 B-treatment
( 55 56 2002 2003 O
confirmed 56 65 2003 2012 O
azoospermia 66 77 2013 2024 B-chronic_disease
) 77 78 2024 2025 O
or 79 81 2026 2028 O
they 82 86 2029 2033 O
and 87 90 2034 2037 O
their 91 96 2038 2043 O
female 97 103 2044 2050 B-gender
partner 104 111 2051 2058 I-gender
must 112 116 2059 2063 O
meet 117 121 2064 2068 O
the 122 125 2069 2072 O
criteria 126 134 2073 2081 O
above 135 140 2082 2087 O

Participants 0 12 2088 2100 O
must 13 17 2101 2105 O
have 18 22 2106 2110 O
recovered 23 32 2111 2120 O
from 33 37 2121 2125 O
any 38 41 2126 2129 O
adverse 42 49 2130 2137 O
effects 50 57 2138 2145 O
from 58 62 2146 2150 O
any 63 66 2151 2154 O
previous 67 75 2155 2163 B-treatment
CTCL 76 80 2164 2168 I-treatment
therapy 81 88 2169 2176 I-treatment
to 89 91 2177 2179 O
Common 92 98 2180 2186 B-clinical_variable
Terminology 99 110 2187 2198 I-clinical_variable
Criteria 111 119 2199 2207 I-clinical_variable
for 120 123 2208 2211 I-clinical_variable
Adverse 124 131 2212 2219 I-clinical_variable
Events 132 138 2220 2226 I-clinical_variable
( 139 140 2227 2228 I-clinical_variable
CTCAE 140 145 2228 2233 I-clinical_variable
) 145 146 2233 2234 I-clinical_variable
Grade 147 152 2235 2240 O
< 153 154 2241 2242 O
2 154 155 2242 2243 B-upper_bound
before 156 162 2244 2250 O
starting 163 171 2251 2259 O
study 172 177 2260 2265 O
drug 178 182 2266 2270 O

Prior 0 5 2271 2276 B-treatment
denileukin 6 16 2277 2287 I-treatment
diftitox 17 25 2288 2296 I-treatment
therapy 26 33 2297 2304 I-treatment

Serious 0 7 2305 2312 O
intercurrent 8 20 2313 2325 B-chronic_disease
illness 21 28 2326 2333 I-chronic_disease

Significant 0 11 2334 2345 O
cardiac 12 19 2346 2353 B-chronic_disease
disease 20 27 2354 2361 I-chronic_disease
requiring 28 37 2362 2371 O
ongoing 38 45 2372 2379 O
treatment 46 55 2380 2389 B-treatment
, 55 56 2389 2390 O
including 57 66 2391 2400 O
congestive 67 77 2401 2411 B-treatment
heart 78 83 2412 2417 I-treatment
failure 84 91 2418 2425 I-treatment
( 92 93 2426 2427 I-treatment
CHF 93 96 2427 2430 I-treatment
) 96 97 2430 2431 I-treatment
, 97 98 2431 2432 O
severe 99 105 2433 2439 O
coronary 106 114 2440 2448 B-chronic_disease
artery 115 121 2449 2455 I-chronic_disease
disease 122 129 2456 2463 I-chronic_disease
( 130 131 2464 2465 I-chronic_disease
CAD 131 134 2465 2468 I-chronic_disease
) 134 135 2468 2469 I-chronic_disease
, 135 136 2469 2470 O
cardiomyopathy 137 151 2471 2485 B-chronic_disease
, 151 152 2485 2486 O
uncontrolled 153 165 2487 2499 O
cardiac 166 173 2500 2507 B-chronic_disease
arrhythmia 174 184 2508 2518 I-chronic_disease
, 184 185 2518 2519 O
unstable 186 194 2520 2528 O
angina 195 201 2529 2535 B-chronic_disease
pectoris 202 210 2536 2544 I-chronic_disease
, 210 211 2544 2545 O
or 212 214 2546 2548 O
myocardial 215 225 2549 2559 B-chronic_disease
infarction 226 236 2560 2570 I-chronic_disease
( 237 238 2571 2572 I-chronic_disease
MI 238 240 2572 2574 I-chronic_disease
) 240 241 2574 2575 I-chronic_disease

Significant 0 11 2576 2587 O
or 12 14 2588 2590 O
uncontrolled 15 27 2591 2603 B-chronic_disease
infections 28 38 2604 2614 I-chronic_disease
requiring 39 48 2615 2624 O
systemic 49 57 2625 2633 B-treatment
anti 58 62 2634 2638 I-treatment
- 62 63 2638 2639 I-treatment
infective 63 72 2639 2648 I-treatment
therapy 73 80 2649 2656 I-treatment

Significant 0 11 2657 2668 O
pulmonary 12 21 2669 2678 B-chronic_disease
symptoms 22 30 2679 2687 I-chronic_disease
or 31 33 2688 2690 I-chronic_disease
disease 34 41 2691 2698 I-chronic_disease

The 0 3 2699 2702 O
concomitant 4 15 2703 2714 O
steroid 16 23 2715 2722 B-treatment
medication 24 34 2723 2733 I-treatment
is 35 37 2734 2736 O
allowed 38 45 2737 2744 O
as 46 48 2745 2747 O
long 49 53 2748 2752 O
as 54 56 2753 2755 O
the 57 60 2756 2759 O
type 61 65 2760 2764 O
of 66 68 2765 2767 O
steroid 69 76 2768 2775 O
, 76 77 2775 2776 O
route 78 83 2777 2782 O
of 84 86 2783 2785 O
administration 87 101 2786 2800 O
, 101 102 2800 2801 O
and 103 106 2802 2805 O
steroid 107 114 2806 2813 O
dose 115 119 2814 2818 O
remain 120 126 2819 2825 O
the 127 130 2826 2829 O
same 131 135 2830 2834 O
as 136 138 2835 2837 O
what 139 143 2838 2842 O
the 144 147 2843 2846 O
participant 148 159 2847 2858 O
had 160 163 2859 2862 O
been 164 168 2863 2867 O
receiving 169 178 2868 2877 O
for 179 182 2878 2881 O
a 183 184 2882 2883 O
prolonged 185 194 2884 2893 O
period 195 201 2894 2900 O
of 202 204 2901 2903 O
time 205 209 2904 2908 O

Topical 0 7 2909 2916 B-treatment
steroids 8 16 2917 2925 I-treatment
or 17 19 2926 2928 O
systemic 20 28 2929 2937 B-treatment
low 29 32 2938 2941 I-treatment
dose 33 37 2942 2946 I-treatment
steroids 38 46 2947 2955 I-treatment
of 47 49 2956 2958 O
less 50 54 2959 2963 O
than 55 59 2964 2968 O
or 60 62 2969 2971 O
equal 63 68 2972 2977 O
to 69 71 2978 2980 O
10 72 74 2981 2983 B-upper_bound
milligram 75 84 2984 2993 I-upper_bound
per 85 88 2994 2997 I-upper_bound
day 89 92 2998 3001 I-upper_bound
( 93 94 3002 3003 I-upper_bound
mg 94 96 3003 3005 I-upper_bound
/ 96 97 3005 3006 I-upper_bound
day 97 100 3006 3009 I-upper_bound
) 100 101 3009 3010 I-upper_bound
prednisone 102 112 3011 3021 B-treatment
are 113 116 3022 3025 O
allowed 117 124 3026 3033 O
in 125 127 3034 3036 O
participants 128 140 3037 3049 O
with 141 145 3050 3054 O
erythroderma 146 158 3055 3067 B-chronic_disease
who 159 162 3068 3071 O
have 163 167 3072 3076 O
been 168 172 3077 3081 O
on 173 175 3082 3084 O
corticosteroids 176 191 3085 3100 B-treatment
for 192 195 3101 3104 O
a 196 197 3105 3106 O
prolonged 198 207 3107 3116 O
period 208 214 3117 3123 O
of 215 217 3124 3126 O
time 218 222 3127 3131 O
and 223 226 3132 3135 O
where 227 232 3136 3141 O
discontinuation 233 248 3142 3157 O
may 249 252 3158 3161 O
lead 253 257 3162 3166 O
to 258 260 3167 3169 O
rebound 261 268 3170 3177 O
flare 269 274 3178 3183 O
in 275 277 3184 3186 O
disease 278 285 3187 3194 O

Topical 0 7 3195 3202 B-treatment
treatments 8 18 3203 3213 I-treatment
( 19 20 3214 3215 O
except 20 26 3215 3221 O
topical 27 34 3222 3229 B-treatment
chemotherapy 35 47 3230 3242 I-treatment
) 47 48 3242 3243 O
and 49 52 3244 3247 O
steroids 53 61 3248 3256 B-treatment
are 62 65 3257 3260 O
not 66 69 3261 3264 O
considered 70 80 3265 3275 O
as 81 83 3276 3278 O
prior 84 89 3279 3284 B-treatment
therapies 90 99 3285 3294 I-treatment

Use 0 3 3295 3298 O
of 4 6 3299 3301 O
topical 7 14 3302 3309 B-treatment
steroids 15 23 3310 3318 I-treatment
within 24 30 3319 3325 O
14 31 33 3326 3328 B-upper_bound
days 34 38 3329 3333 I-upper_bound
of 39 41 3334 3336 O
Day 42 45 3337 3340 O
1 46 47 3341 3342 O
of 48 50 3343 3345 O
initial 51 58 3346 3353 O
therapy 59 66 3354 3361 B-treatment
is 67 69 3362 3364 O
not 70 73 3365 3368 O
allowed 74 81 3369 3376 O

albumin 0 7 3377 3384 B-clinical_variable
greater 8 15 3385 3392 O
than 16 20 3393 3397 O
or 21 23 3398 3400 O
equal 24 29 3401 3406 O
to 30 32 3407 3409 O
3.0 33 36 3410 3413 B-lower_bound
g 37 38 3414 3415 I-lower_bound
/ 38 39 3415 3416 I-lower_bound
dL 39 41 3416 3418 I-lower_bound
( 42 43 3419 3420 I-lower_bound
30 43 45 3420 3422 I-lower_bound
g 46 47 3423 3424 I-lower_bound
/ 47 48 3424 3425 I-lower_bound
L 48 49 3425 3426 I-lower_bound
) 49 50 3426 3427 I-lower_bound

aspartate 0 9 3428 3437 B-clinical_variable
aminotransferase 10 26 3438 3454 I-clinical_variable
( 27 28 3455 3456 I-clinical_variable
AST 28 31 3456 3459 I-clinical_variable
) 31 32 3459 3460 I-clinical_variable
less 33 37 3461 3465 O
than 38 42 3466 3470 O
or 43 45 3471 3473 O
equal 46 51 3474 3479 O
to 52 54 3480 3482 O
75 55 57 3483 3485 B-upper_bound
U 58 59 3486 3487 I-upper_bound
/ 59 60 3487 3488 I-upper_bound
L 60 61 3488 3489 I-upper_bound
and 62 65 3490 3493 O
alanine 66 73 3494 3501 B-clinical_variable
aminotransferase 74 90 3502 3518 I-clinical_variable
( 91 92 3519 3520 I-clinical_variable
ALT 92 95 3520 3523 I-clinical_variable
) 95 96 3523 3524 I-clinical_variable
less 97 101 3525 3529 O
than 102 106 3530 3534 O
or 107 109 3535 3537 O
equal 110 115 3538 3543 O
to 116 118 3544 3546 O
100 119 122 3547 3550 B-upper_bound
U 123 124 3551 3552 I-upper_bound
/ 124 125 3552 3553 I-upper_bound
L 125 126 3553 3554 I-upper_bound

bilirubin 0 9 3555 3564 B-clinical_variable
and 10 13 3565 3568 O
alkaline 14 22 3569 3577 B-clinical_variable
phosphatase 23 34 3578 3589 I-clinical_variable
less 35 39 3590 3594 O
than 40 44 3595 3599 O
or 45 47 3600 3602 O
equal 48 53 3603 3608 O
to 54 56 3609 3611 O
1 57 58 3612 3613 B-upper_bound
x 59 60 3614 3615 I-upper_bound
the 61 64 3616 3619 O
upper 65 70 3620 3625 B-clinical_variable
limit 71 76 3626 3631 I-clinical_variable
of 77 79 3632 3634 I-clinical_variable
normal 80 86 3635 3641 I-clinical_variable
( 87 88 3642 3643 I-clinical_variable
ULN 88 91 3643 3646 I-clinical_variable
) 91 92 3646 3647 I-clinical_variable

calculated 0 10 3648 3658 B-clinical_variable
creatinine 11 21 3659 3669 I-clinical_variable
clearance 22 31 3670 3679 I-clinical_variable
greater 32 39 3680 3687 O
than 40 44 3688 3692 O
or 45 47 3693 3695 O
equal 48 53 3696 3701 O
to 54 56 3702 3704 O
50 57 59 3705 3707 B-lower_bound
mL 60 62 3708 3710 I-lower_bound
/ 62 63 3710 3711 I-lower_bound
min 63 66 3711 3714 I-lower_bound
( 67 68 3715 3716 O
per 68 71 3716 3719 O
the 72 75 3720 3723 O
Cockcroft 76 85 3724 3733 B-clinical_variable
- 85 86 3733 3734 I-clinical_variable
Gault 86 91 3734 3739 I-clinical_variable
formula 92 99 3740 3747 I-clinical_variable
) 99 100 3747 3748 O
with 101 105 3749 3753 O
less 106 110 3754 3758 O
than 111 115 3759 3763 O
2 116 117 3764 3765 B-upper_bound
+ 117 118 3765 3766 I-upper_bound
protein 119 126 3767 3774 O
OR 127 129 3775 3777 O
24- 130 133 3778 3781 O
hour 134 138 3782 3786 O
urine 139 144 3787 3792 O
creatinine 145 155 3793 3803 O
clearance 156 165 3804 3813 O
greater 166 173 3814 3821 O
than 174 178 3822 3826 O
or 179 181 3827 3829 O
equal 182 187 3830 3835 O
to 188 190 3836 3838 O
50 191 193 3839 3841 B-lower_bound
mL 194 196 3842 3844 I-lower_bound
/ 196 197 3844 3845 I-lower_bound
minute 197 203 3845 3851 I-lower_bound
with 204 208 3852 3856 O
24- 209 212 3857 3860 O
hour 213 217 3861 3865 O
urine 218 223 3866 3871 O
protein 224 231 3872 3879 O
less 232 236 3880 3884 O
than 237 241 3885 3889 O
1 242 243 3890 3891 B-upper_bound
g 243 244 3891 3892 I-upper_bound

clinically 0 10 3893 3903 O
stable 11 17 3904 3910 O
hemoglobin 18 28 3911 3921 B-clinical_variable
greater 29 36 3922 3929 O
than 37 41 3930 3934 O
or 42 44 3935 3937 O
equal 45 50 3938 3943 O
to 51 53 3944 3946 O
9 54 55 3947 3948 B-lower_bound
g 56 57 3949 3950 I-lower_bound
/ 57 58 3950 3951 I-lower_bound
dL 58 60 3951 3953 I-lower_bound
( 61 62 3954 3955 I-lower_bound
90 62 64 3955 3957 I-lower_bound
g 65 66 3958 3959 I-lower_bound
/ 66 67 3959 3960 I-lower_bound
L 67 68 3960 3961 I-lower_bound
) 68 69 3961 3962 I-lower_bound
and 70 73 3963 3966 O
hematocrit 74 84 3967 3977 B-clinical_variable
greater 85 92 3978 3985 O
than 93 97 3986 3990 O
or 98 100 3991 3993 O
equal 101 106 3994 3999 O
to 107 109 4000 4002 O
27 110 112 4003 4005 B-lower_bound
% 112 113 4005 4006 I-lower_bound
without 114 121 4007 4014 O
transfusion 122 133 4015 4026 B-treatment
support 134 141 4027 4034 I-treatment

platelets 0 9 4035 4044 B-clinical_variable
greater 10 17 4045 4052 O
than 18 22 4053 4057 O
or 23 25 4058 4060 O
equal 26 31 4061 4066 O
to 32 34 4067 4069 O
100,000 35 42 4070 4077 B-lower_bound
/ 42 43 4077 4078 I-lower_bound
mm3 43 46 4078 4081 I-lower_bound
( 47 48 4082 4083 I-lower_bound
100 48 51 4083 4086 I-lower_bound
x 52 53 4087 4088 I-lower_bound
10 54 56 4089 4091 I-lower_bound
^ 56 57 4091 4092 I-lower_bound
9 57 58 4092 4093 I-lower_bound
/ 58 59 4093 4094 I-lower_bound
L 59 60 4094 4095 I-lower_bound
) 60 61 4095 4096 I-lower_bound

